Termination by Stanford Clause Samples

Termination by Stanford. (A) Stanford may terminate this Agreement if Licensee: (1) Is in default in payment of royalty; or (2) Is in breach of any provision. (B) Termination under this Section 9.2 will take effect 30 days after written notice by Stanford unless Licensee remedies the problem in that 30-day period.

Termination by Stanford. (A) Stanford may also terminate this Agreement if ImmuMetrix: (1) is delinquent on any report or payment; (2) is not diligently developing and commercializing Licensed Product; (3) misses a milestone described in Appendix A; (4) is in breach of any provision; or (5) provides any false report. (B) Termination under this Section 15.2 will take effect 30 days after written notice by Stanford specifying the nature of the default or breach unless ImmuMetrix remedies the problem in that 30-day period. Notwithstanding the foregoing, if ImmuMetrix disputes any such default or breach in writing within such 30-day period, Stanford shall not have the right to terminate this Agreement unless and until the arbitrator determines in a written decision delivered to the parties under Section 17 below, that such default or breach occurred, and ImmuMetrix fails to cure such default or breach within 30 days after such determination. Each party shall use reasonable efforts to conclude such arbitration within thirty (30) days of the initiation of such arbitration.

Termination by Stanford. (A) Stanford may also terminate this Agreement if Eidos: (1) is delinquent on any report or payment under this Agreement; (2) is not diligently using commercially reasonable efforts in developing and commercializing Licensed Product (directly or through an Affiliate or sublicensee); (3) misses a milestone described in Appendix A, provided that parties have completed the process set forth in Section 6.1 (4) is in material breach of any material provision of this Agreement; or (5) knowingly provides any false report to Stanford under this Agreement. (B) Termination under this Section 15.2 will take effect 30 days after written notice by Stanford unless Eidos remedies the problem in that 30-day period.

Termination by Stanford. (A) Stanford may also terminate this Agreement if Forty Seven on 30 days’ written notice: (1) is in material default in the payment of amounts due hereunder or the provision on any report; (2) is not using commercially reasonable efforts in developing and commercializing Licensed Product; (3) is in material breach of any provision; or (4) provides any materially false report. (B) In the event Forty Seven misses a milestone described in Appendix A, Stanford may terminate the license for the applicable Deficient Product under this Agreement for which such milestone was missed and any Licensed Patent(s) solely covering such Deficient Product, subject to Forty Seven’s right to extend the timeline for milestones pursuant to Section 6.1. (C) Termination under this Section 15.2 will take effect 30 days after written notice by Stanford unless Forty Seven remedies the problem in that 30-day period.

Termination by Stanford. (A) Stanford may also terminate this Agreement if Medicenna: (1) is delinquent on any report or payment; (2) is not diligently developing and commercializing Licensed Product; (3) misses a milestone described in Appendix A; (4) is in material breach of any provision; or (5) provides any intentionally false report. (B) Termination under this Section 15.2 will take effect where such breach has not been remedied within ninety (90) days from Medicenna’s receipt of written notice from Stanford setting out details of the breach and requiring such remedy, provided however, that if the breach is not capable of being cured within ninety (90) days of such written notice, the Agreement may not be terminated so long as Medicenna commences and is taking Commercially Reasonable Efforts to cure such breach as promptly as practical, but not longer than one hundred and twenty (120) days after such written notice. In any event, if a curable breach has not been cured within ninety (90) days after notice requesting cure, Stanford shall have the right, at its option, to terminate this Agreement. In the event that a particular Licensed Patent is not being developed as a Licensed Product per the milestones of Appendix A, as may be amended from time to time, and subject to the cure provision in this Section 15.2, Stanford’s right to terminate shall apply to only such particular Licensed Patent and not to the Exclusive (Equity) Agreement as a whole.

Termination by Stanford. (A) Stanford may also terminate this Agreement if Licensee: (1) is delinquent on any payment; (2) is in breach of any provision; or (B) Termination under this Section 9.2 will take effect 30 days after written notice by Stanford unless Licensee remedies the problem in that 30-day period. (C) As of the effective date of termination, Licensee will: (1) cease use of Biological Material; and (2) return to Stanford or destroy all Biological Material.

Termination by Stanford. Stanford may terminate this Agreement upon thirty (30) days written notice to Company if Company is in material breach of its obligations, including but not limited to its payment obligations under Article 6 herein, unless, before the end of the thirty (30) day period, Company has cured the breach or default to the reasonable satisfaction of Stanford and so notifies Stanford in writing, stating the manner of the cure.

Termination by Stanford. (A) Stanford may also terminate this Agreement if Telomolecular: (1) is delinquent on any report or payment; (2) is not diligently developing and commercializing Licensed Product; (3) misses a milestone described in Appendix A; (4) is in breach of any provision; or (5) provides any false report. (B) Termination under this Section 14.2 will take effect 30 days after written notice by Stanford unless Telornolecular remedies the problem in that 30- day period.

Termination by Stanford. (A) Stanford may also terminate this Agreement on a Licensed Product-by-Licensed product basis if Alexo: (1) is delinquent on any report or payment; (2) is not diligently developing and commercializing Licensed Product with respect to a market or indication and a third party seeks rights with respect to such indication or market and Alexo does not within [***] either (A) [***] or (B) [***]; (3) misses a milestone described in Appendix A; (4) is in breach of any provision of this Agreement; or (5) provides any false report. (B) Termination under this Section 15.2 will take effect 60 days after written notice by Stanford unless Alexo remedies the problem in that 60-day period. *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a confidential treatment request.